Article · 28 Feb 2025
Research articlePublished 3 May 2019
A validated RP-HPLC method for estimation of Rivastigmine in pharmaceutical formulations
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
An isocratic RP-HPLC Method for analysis of Rivastigmine in pharmaceutical dosage forms has been developed and validated. Best separation was achieved on a Thermo Hypersil C4 column (25 cm X 4.6 mm, 5 μm) using a mobile phase of 0.01 M ammonium acetate buffer adjusted to pH 4.0 with orthophosphoric acid and Acetonitrile (60:40, v/v) at a flow rate of 1.0 mL min-1. UV detection was performed at 220 nm. Atrovastatin was used as an internal standard. The retention time of Rivastigmine and Atrovastatin was 4.75 and 8.83 min, respectively. The method was validated for specificity, linearity, precision, accuracy, and limit of quantification, limit of detection, robustness, and solution stability. The proposed method was applied for the quantitative determination of Rivastigmine in commercial formulations.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Der Pharmacia Lettre.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “S. Alexandar”
- BylineArticles whose byline prints “Rohini Diwedi”
- BylineArticles whose byline prints “T. Ashok”
- BylineArticles whose byline prints “M. J. N. Chandrasekhar”